產(chǎn)品搜索
相關(guān)文章
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌(NSCLC)
- 從諾輝財(cái)報(bào)看甲基化市場(chǎng),科佰生物助力甲基化標(biāo)準(zhǔn)品的開(kāi)發(fā)
- GLP1R藥靶篩選模型應(yīng)用展示
- 拯救偏頭痛!CGRP及其受體拮抗劑研究進(jìn)展
- 【產(chǎn)品推介】RANKL抗體篩選模型
- ATCC細(xì)胞的實(shí)驗(yàn)要點(diǎn)及說(shuō)明
- CD27細(xì)胞篩選模型
- 黑色素瘤研究進(jìn)展一覽
- CD200/CD200R篩選模型
- 認(rèn)識(shí)下北京細(xì)胞庫(kù)的質(zhì)量管理要求
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73296c-Kit A502_Y503dup/BaF3

- 詳細(xì)內(nèi)容
CBP73296 | |
I. Introduction | |
Cell Line Name: | c-Kit A502_Y503dup/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II. Background | |
KIT A502_Y503dup (also referred to as Y503_F504insAY) indicates the insertion of 2 duplicate amino acids, alanine (A)-502 through tyrosine (Y)-503, in the Ig-like C2-type domain 5 (exon 9) of the Kit protein . A502_Y503dup results in constitutive phosphorylation of Kit and is transforming in cell culture. | |
III. Representative Data | |
1. WB of c-Kit A502_Y503dup/BaF3 | |
2. Sanger of c-Kit A502_Y503dup/BaF3 | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 C-KIT A502_Y503dup Cells (C5). |